Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease (EVINCI)
Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease
Sponsor: European Commission
Listed as NCT00979199, this PHASE4 trial focuses on Ischemic Heart Disease and remains completed. Sponsored by European Commission, it has been updated 8 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Feb 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Commission
- Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Barcelona, Spain , Genova, Italy , Göppingen, Germany , Leiden, Netherlands , London, United Kingdom , Madrid, Spain , Munich, Germany , Naples, Italy , Paris, France , Pisa, Italy and 4 more locations